PE20141565A1 - Metodos para detectar papilomavirus humano y proporcionar pronostico para carcinoma de celulas escamosas de cabeza y cuello - Google Patents

Metodos para detectar papilomavirus humano y proporcionar pronostico para carcinoma de celulas escamosas de cabeza y cuello

Info

Publication number
PE20141565A1
PE20141565A1 PE2014000699A PE2014000699A PE20141565A1 PE 20141565 A1 PE20141565 A1 PE 20141565A1 PE 2014000699 A PE2014000699 A PE 2014000699A PE 2014000699 A PE2014000699 A PE 2014000699A PE 20141565 A1 PE20141565 A1 PE 20141565A1
Authority
PE
Peru
Prior art keywords
scamous
neck
cell carcinoma
head
methods
Prior art date
Application number
PE2014000699A
Other languages
English (en)
Inventor
Elizabeth Franzmann
Lutecia Pereira
Isildinha M Reis
Robert C Duncan
Original Assignee
Univ Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Miami filed Critical Univ Miami
Publication of PE20141565A1 publication Critical patent/PE20141565A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5751—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70585—CD44
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE REFIERE A UN METODO PARA DIAGNOSTICAR EL CARCINOMA DE CELULAS ESCAMOSAS DE CABEZA Y CUELLO (HNSCC) EN UN SUJETO, QUE COMPRENDE ENSAYAR UNA MUESTRA DE SALIVA DEL SUJETO CON RESPECTO A LA PRESENCIA DE PROTEINAS TOTALES, SOLCD44 Y HPV, Y USAR LA COMBINACION DE LOS NIVELES DE PROTEINA TOTAL, HPV Y CD44 EN UN ANALISIS MULTIVARIANTE PARA DETERMINAR UNA PUNTUACION COMBINADA, POR LA QUE UN AUMENTO EN LA PUNTUACION POR ENCIMA DE UN PUNTO DE CORTE DISTINGUE SUJETOS CON HNSCC, O UN RIESGO ELEVADO DE APARICION FUTURA DE ESTE.
PE2014000699A 2011-11-15 2012-11-15 Metodos para detectar papilomavirus humano y proporcionar pronostico para carcinoma de celulas escamosas de cabeza y cuello PE20141565A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161559974P 2011-11-15 2011-11-15
US201261654595P 2012-06-01 2012-06-01

Publications (1)

Publication Number Publication Date
PE20141565A1 true PE20141565A1 (es) 2014-10-25

Family

ID=48430146

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2014000699A PE20141565A1 (es) 2011-11-15 2012-11-15 Metodos para detectar papilomavirus humano y proporcionar pronostico para carcinoma de celulas escamosas de cabeza y cuello

Country Status (13)

Country Link
US (3) US20140329230A1 (es)
EP (1) EP2780714B1 (es)
JP (1) JP6174035B2 (es)
CN (1) CN104067126B (es)
AU (3) AU2012340441A1 (es)
BR (1) BR112014011563B1 (es)
CA (1) CA2855971C (es)
CO (1) CO6980621A2 (es)
ES (1) ES2640532T3 (es)
IL (1) IL232556A (es)
MX (1) MX352642B (es)
PE (1) PE20141565A1 (es)
WO (1) WO2013074793A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013074793A1 (en) 2011-11-15 2013-05-23 University Of Miami Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma
KR102320503B1 (ko) * 2013-07-31 2021-11-03 더 유니버시티 오브 마이애미 대상체에서 암 위험을 동정하는 조성물 및 방법
EP3036345A2 (en) * 2013-08-19 2016-06-29 Notre Dame Du Lac Method and composition for detection of oncogenic hpv
WO2015179712A1 (en) 2014-05-22 2015-11-26 University Of Notre Dame Du Lac Integrated membrane sensor for rapid molecular detection
US11268153B2 (en) 2015-06-22 2022-03-08 The Johns Hopkins University Head and neck squamous cell carcinoma assays
JP6655243B2 (ja) * 2015-09-01 2020-02-26 国立大学法人 鹿児島大学 口腔前癌病変の検出方法
CN107092854B (zh) * 2016-02-18 2020-05-22 财团法人金属工业研究发展中心 检测细胞受人类乳头瘤病毒(hpv)感染的装置及其检测方法
GB201808839D0 (en) * 2018-05-30 2018-07-11 Cancer Research Tech Ltd Method of predicting survival rates for cancer patients
WO2020018954A1 (en) * 2018-07-20 2020-01-23 Predentome, Inc. Methods and systems for oral microbiome analysis
US20220137041A1 (en) * 2019-02-26 2022-05-05 University Of Miami Device for methods of detecting cancer
WO2022226153A1 (en) * 2021-04-23 2022-10-27 The University Of Chicago Machine learning based histopathological recurrence prediction models for hpv+ head / neck squamous cell carcinoma
US20250327804A1 (en) * 2022-10-17 2025-10-23 Vigilant Biosciences, Inc. Methods and Compositions for Oral Cancer Risk

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5403551A (en) 1993-09-16 1995-04-04 Roche Diagnostic Systems, Inc. Assaying device and container for in field analysis of a specimen and later shipment of the unadulterated specimen
US6235470B1 (en) 1993-11-12 2001-05-22 The Johns Hopkins University School Of Medicine Detection of neoplasia by analysis of saliva
US5990299A (en) * 1995-08-14 1999-11-23 Icn Pharmaceuticals, Inc. Control of CD44 gene expression for therapeutic use
US5976895A (en) 1996-03-11 1999-11-02 American Biomedica Corporation Device for the collection, testing and shipment of body fluid samples
DE19829473C2 (de) * 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
US6379620B1 (en) 1998-11-16 2002-04-30 Barry M. Tydings Assaying device and method for in field urinalysis
US6294349B1 (en) 1999-03-01 2001-09-25 University Of Mississippi Medical Ctr. Method of diagnosing and monitoring malignant breast carcinomas
US7189397B2 (en) 1999-10-08 2007-03-13 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US20040029114A1 (en) 2001-01-24 2004-02-12 Eos Technology, Inc. Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
DE60300339T2 (de) * 2003-08-25 2006-04-13 Mtm Laboratories Ag Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben
JP4563186B2 (ja) 2004-02-16 2010-10-13 理研ビタミン株式会社 耐熱性が改善されたアントシアニン色素
WO2005095987A2 (en) * 2004-03-26 2005-10-13 University Of Miami Salivary soluble cd44: a molecular marker for head and neck cancer
WO2007129999A2 (en) 2004-07-14 2007-11-15 Biospectrum, Inc. Antiproliferative peptides and antibodies for their detection
CN103245784A (zh) 2005-11-10 2013-08-14 肯塔基大学研究基金会 肺癌的诊断分析法
AU2007249805B2 (en) 2006-05-12 2013-01-10 University Of Miami Biomarkers for detection and diagnosis of head and neck squamous cell carcinoma
CN101230390A (zh) * 2007-12-07 2008-07-30 湖北大学 一种用于妇科恶性肿瘤早期筛选的基因芯片及其检测方法
EP2364371A4 (en) * 2008-11-24 2012-05-02 Univ Loma Linda BIOMARKER FOR DETECTING HEADS AND HALSTUMORS
WO2013074793A1 (en) 2011-11-15 2013-05-23 University Of Miami Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma

Also Published As

Publication number Publication date
IL232556A0 (en) 2014-06-30
ES2640532T3 (es) 2017-11-03
MX2014005887A (es) 2014-09-08
CN104067126B (zh) 2017-04-12
US20160305942A1 (en) 2016-10-20
AU2020277155A1 (en) 2020-12-24
AU2018203361A1 (en) 2018-05-31
CA2855971C (en) 2022-01-04
AU2012340441A1 (en) 2014-05-29
EP2780714A1 (en) 2014-09-24
CN104067126A (zh) 2014-09-24
BR112014011563B1 (pt) 2022-05-24
EP2780714B1 (en) 2017-08-16
US20150219656A1 (en) 2015-08-06
JP2014533372A (ja) 2014-12-11
WO2013074793A1 (en) 2013-05-23
BR112014011563A2 (pt) 2017-05-09
AU2018203361B2 (en) 2020-08-27
CO6980621A2 (es) 2014-06-27
US20140329230A1 (en) 2014-11-06
CA2855971A1 (en) 2013-05-23
US10180430B2 (en) 2019-01-15
IL232556A (en) 2017-12-31
JP6174035B2 (ja) 2017-08-02
EP2780714A4 (en) 2015-07-15
US10180431B2 (en) 2019-01-15
MX352642B (es) 2017-12-01

Similar Documents

Publication Publication Date Title
PE20141565A1 (es) Metodos para detectar papilomavirus humano y proporcionar pronostico para carcinoma de celulas escamosas de cabeza y cuello
GB201120209D0 (en) Methods of monitoring conditions by sequence analysis
AR102615A1 (es) Analizador de analitos
MX2015015532A (es) Metodo y sistema de identificacion de biomarcadores.
MX2018008421A (es) Métodos para tratar cáncer y el uso de biomarcadores como predictor de sensibilidad clínica a terapias.
CL2012001980A1 (es) Uso de un anticuerpo monoclonal anti-cd44 o fragmento de unión del mismo, en el tratamiento del carcinoma escamocelular de cabeza y cuello (hnscc) en un mamífero, donde el hnscc se distingue según la expresión de cd44.
BR112014031981A2 (pt) método para a visualização de um lúmen ramificado; e sistema para o monitoramento de um vaso sanguíneo
NZ578283A (en) Proteomic profiling method useful for condition diagnosis and monitoring, composition screening, and therapeutic monitoring
MX374971B (es) Metodos y aparato para la deteccion de sensibilidad al gluten y su diferenciacion de la enfermedad celiaca
GB201201766D0 (en) Method
BR112015019567A2 (pt) marcadores associados com inibidores de wnt
EA201391634A1 (ru) Приспособление и метод для неинвазивного сбора содержащего клетки слоя колоректальной слизи и выявления заболеваний
MX2017014196A (es) Deteccion de factores de virulencia microbiana bucal.
MX358474B (es) Biomarcadores salivales específicos para detección de riesgo, diagnóstico temprano, pronóstico y vigilancia de las enfermedades de alzheimer y de parkinson.
PE20160657A1 (es) Composiciones y metodos para identificar un riesgo de cancer en un sujeto
CL2011003218A1 (es) Metodo para determinar la susceptibilidad de un sujeto a un virus; metodo para detectar replicacion viral en una muestra de tejido; en aves y salmon.
ES2619569T3 (es) Método de ensayo de infección o inflamación de las vías respiratorias inferiores
BR112014009144A2 (pt) avaliação do risco de pml e métodos com base na mesma
ES2660763T3 (es) Sonda codificada genéticamente para la cuantificación de la concentración de piruvato y métodos de utilización del mismo
BR112016002709A2 (pt) queratinas como biomarcadores para câncer cervical e sobrevivência
AR087654A1 (es) METODO DIAGNOSTICO DE ANIMALES VACUNADOS CON PESTIVIRUS QUIMERICO EN EL CUAL LA PROTEINA Eʳⁿˢ DEL VIRUS DE LA DIARREA VIRAL BOVINA (BVDV) ES REMPLAZADA POR PROTEINA Eʳⁿˢ DE PESTIVIRUS DE ANTILOPE AMERICANO
FR2971846B1 (fr) Procede d'observation d'un echantillon
MX2012005388A (es) Reactivos y metodos para detectar globulos blancos pnh tipo ii y su identificacion como factores de riesgo para transtornos trombolicos.
AU2013231230A8 (en) Method for selecting or identifying a subject for V1B antagonist therapy
AR068449A1 (es) Analisis de enfermedades infecciosas en fluido menstrual, celulas endometriales / menstruales , fluido amniotico , sangre de cordon umbilical u otras muestras

Legal Events

Date Code Title Description
FC Refusal